A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Public ClinicalTrials.gov record NCT01421667. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL)
Study identification
- NCT ID
- NCT01421667
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Seagen Inc.
- Industry
- Enrollment
- 176 participants
Conditions and interventions
Interventions
- brentuximab vedotin Drug
- rituximab Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2011
- Primary completion
- May 31, 2015
- Completion
- May 31, 2015
- Last update posted
- Nov 27, 2016
2011 – 2015
United States locations
- U.S. sites
- 33
- U.S. states
- 18
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294-3300 | — |
| City of Hope | Duarte | California | 91010-3000 | — |
| PMK Medical Group Inc., DBA Ventura County Hematology Oncology Specialists | Oxnard | California | 93030 | — |
| Stanford Cancer Center | Stanford | California | 94305-5821 | — |
| Rocky Mountain Cancer Centers - Aurora | Aurora | Colorado | 80012 | — |
| Colorado Blood Cancer Institute | Denver | Colorado | 80218 | — |
| Cancer Specialists of North Florida - St. Augustine | Saint Augustine | Florida | 32086 | — |
| Emory Winship Cancer Institute | Atlanta | Georgia | 30322 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| University of Chicago | Chicago | Illinois | 60637-1470 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| Minnesota Oncology Hematology P.A. | Minneapolis | Minnesota | 55404 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89169 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| New York Oncology Hematology, P.C. | Albany | New York | 12206 | — |
| NYU Clinical Cancer Center | New York | New York | 10016 | — |
| Columbia University Medical Center | New York | New York | 10019 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10021 | — |
| Cleveland Clinic, The | Cleveland | Ohio | 44195 | — |
| Willamette Valley Cancer and Research / USOR | Eugene | Oregon | 97401 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| St. Francis Hospital | Greenville | South Carolina | 29605 | — |
| Texas Oncology - Medical City Dallas | Dallas | Texas | 75230 | — |
| Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | — |
| Texas Oncology-Southwest Fort Worth | Fort Worth | Texas | 76132 | — |
| MD Anderson Cancer Center / University of Texas | Houston | Texas | 77030-4003 | — |
| Texas Oncology - Seton Williamson | Round Rock | Texas | 78665 | — |
| Texas Oncology - Tyler | Tyler | Texas | 75702 | — |
| Virginia Cancer Specialists, PC | Fairfax | Virginia | 22031 | — |
| Swedish Cancer Institute Medical Oncology | Edmonds | Washington | 98026 | — |
| Seattle Cancer Care Alliance / University of Washington Medical Center | Seattle | Washington | 98109 | — |
| Northwest Cancer Specialists, P.C. | Vancouver | Washington | 98684 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01421667, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 27, 2016 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01421667 live on ClinicalTrials.gov.